Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/33028
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bellomo, Rinaldo | - |
dc.contributor.author | Ronco, Claudio | - |
dc.date | 2023 | - |
dc.date.accessioned | 2023-06-07T02:47:19Z | - |
dc.date.available | 2023-06-07T02:47:19Z | - |
dc.date.issued | 2023-06-01 | - |
dc.identifier.citation | Contributions to Nephrology 2023; 200 | en_US |
dc.identifier.issn | 1662-2782 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/33028 | - |
dc.description.abstract | The Jafron series of sorbent cartridges provides a comprehensive array of coated, highly biocompatible sorbent beads made of styrene-divinylbenzene copolymers. Such beads carry a mean diameter of 0.8 mm with a range from 0.60 to 1.18 mm. The maximal pore size of these coated beads and the volume of the cartridge vary according to the type of cartridge ranging between 50 Da and 60 kDa. The sorbents, the size of the cartridge, the volume of sorbent, and the pore size (which reaches 60 kDa with the HA330 cartridge) aim to take advantage of the principles of molecular adsorption in a variety of diseases from uremic toxin retention to poisoning and drug overdose, from kidney disease to liver failure, from acute respiratory distress syndrome to sepsis, from toxic skin injury to COVID-19. The preliminary data from ex vivo studies, animal investigations, and human pilot work look promising and justify a program of systematic investigation of these products to advance our understanding of how they may be incorporated into our therapeutic arsenal. | en_US |
dc.language.iso | eng | - |
dc.title | Clinical Applications of Adsorption: The New Era of Jafron Sorbents. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Contributions to Nephrology | en_US |
dc.identifier.affiliation | Department of Critical Care, School of Medicine, The University of Melbourne, Parkville, Melbourne, Victoria, Australia | en_US |
dc.identifier.affiliation | International Renal Research Institute, Vicenza, Italy | en_US |
dc.identifier.affiliation | Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia | en_US |
dc.identifier.affiliation | Data Analytics Research and Evaluation (DARE) Centre | en_US |
dc.identifier.affiliation | Intensive Care | en_US |
dc.identifier.affiliation | Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Victoria, Australia | en_US |
dc.identifier.affiliation | Department of Nephrology, San Bortolo Hospital, Vicenza, Italy. | en_US |
dc.identifier.doi | 10.1159/000529845 | en_US |
dc.type.content | Text | en_US |
dc.identifier.pubmedid | 37263197 | - |
dc.description.volume | 200 | - |
dc.description.startpage | 1 | - |
dc.description.endpage | 7 | - |
local.name.researcher | Bellomo, Rinaldo | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
crisitem.author.dept | Intensive Care | - |
crisitem.author.dept | Data Analytics Research and Evaluation (DARE) Centre | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.